Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $18.6 million.

  • Praxis Precision Medicines' Shares Outstanding (Weighted Average) rose 18.52% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 18.52%. This contributed to the annual value of $18.6 million for FY2024, which is 117.48% up from last year.
  • As of FY2024, Praxis Precision Medicines' Shares Outstanding (Weighted Average) stood at $18.6 million, which was up 117.48% from $8.6 million recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' Shares Outstanding (Weighted Average) peaked at $18.6 million during FY2024, and registered a low of $2.6 million during FY2020.
  • Over the past 3 years, Praxis Precision Medicines' median Shares Outstanding (Weighted Average) value was $8.6 million (recorded in 2023), while the average stood at $10.1 million.
  • Data for Praxis Precision Medicines' Shares Outstanding (Weighted Average) shows a peak YoY surged of 172.82% (in 2023) over the last 5 years.
  • Praxis Precision Medicines' Shares Outstanding (Weighted Average) (Yearly) stood at $2.6 million in 2020, then grew by 17.23% to $3.0 million in 2021, then rose by 5.04% to $3.1 million in 2022, then spiked by 172.82% to $8.6 million in 2023, then skyrocketed by 117.48% to $18.6 million in 2024.